Literature DB >> 1933597

Is there a role for vitamin D in osteoporosis?

C Lamberg-Allardt1.   

Abstract

Vitamin D has certain clearly defined effects on bone: vitamin D deficiency results in defective bone mineralization, whereas 1,25-dihydroxy-vitamin D3 (1,25-(OH)2D3) stimulates bone resorption. Studies of the use of 1,25-(OH)2D3 to prevent or treat osteoporosis have given conflicting results concerning bone remodeling. However, 1,25-(OH)2D3 or other vitamin D metabolites seem to play a role in the correction of calcium malabsorption, which is a common feature in osteoporosis.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1933597     DOI： 10.1007/bf02555088

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


  55 in total

1.  Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss?

Authors:  B J Riis; K Thomsen; C Christiansen
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

2.  Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor.

Authors:  R L Horst; J P Goff; T A Reinhardt
Journal:  Endocrinology       Date:  1990-02       Impact factor: 4.736

3.  The influence of age on bone mineral regulating hormones.

Authors:  S Epstein; G Bryce; J W Hinman; O N Miller; B L Riggs; S L Hui; C C Johnston
Journal:  Bone       Date:  1986       Impact factor: 4.398

4.  Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.

Authors:  G F Jensen; B Meinecke; J Boesen; I Transbøl
Journal:  Clin Orthop Relat Res       Date:  1985 Jan-Feb       Impact factor: 4.176

5.  Comparison of the effects of 1,25-dihydroxycholecalciferol, prostaglandin E2, and osteoclast-activating factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats.

Authors:  M E Holtrop; L G Raisz
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

6.  Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.

Authors:  G F Jensen; C Christiansen; I Transbøl
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

7.  Calcitriol in the treatment of postmenopausal osteoporosis.

Authors:  J F Aloia; A Vaswani; J K Yeh; K Ellis; S Yasumura; S H Cohn
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

8.  Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.

Authors:  R W Boyce; S E Weisbrode
Journal:  Lab Invest       Date:  1983-06       Impact factor: 5.662

9.  Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3.

Authors:  T Nakamura; T Kurokawa; H Orimo
Journal:  Calcif Tissue Int       Date:  1988-10       Impact factor: 4.333

10.  Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women.

Authors:  C Cheema; B F Grant; R Marcus
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808
View more
  1 in total

1.  Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives.

Authors:  Hiroyuki Masuno; Teikichi Ikura; Daisuke Morizono; Isamu Orita; Sachiko Yamada; Masato Shimizu; Nobutoshi Ito
Journal:  J Lipid Res       Date:  2013-05-30       Impact factor: 5.922
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.